Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reisa Sperling

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2016
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summitJosé L Molinuevo, Jordi Cami, Xavier Carné, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's diseaseEric Siemers, Todd Feaster, Gopalan Sethuraman, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Nature Medicine|May 6, 2024
APOE4 homozygozity represents a distinct genetic form of Alzheimer's diseaseJuan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension StudyStephen P Salloway, Reisa Sperling, Nick C Fox, et al.
Annals of Neurology|November 22, 2023
Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital TestingKathryn V Papp, Roos J Jutten, Daniel Soberanes, et al.
Nature Reviews. Neurology|September 22, 2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseEric McDade, Iryna Voytyuk, Paul Aisen, et al.
Alzheimer'S Research & Therapy|May 2, 2023
Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitmentDylan R Kirn, Joshua D Grill, Paul Aisen, et al.
The Lancet. Neurology|October 19, 2016
Research priorities to reduce the global burden of dementia by 2025Hiral Shah, Emiliano Albanese, Cynthia Duggan, et al.
The Journal of Prevention of Alzheimer'S Disease|April 8, 2026
Late-life body mass index and amyloid interaction on cognitive decline in unimpaired older adultsWai-Ying Wendy Yau, Rema Raman, Jasmeer Chhatwal, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2016
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summitJosé L Molinuevo, Jordi Cami, Xavier Carné, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's diseaseEric Siemers, Todd Feaster, Gopalan Sethuraman, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Nature Medicine|May 6, 2024
APOE4 homozygozity represents a distinct genetic form of Alzheimer's diseaseJuan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension StudyStephen P Salloway, Reisa Sperling, Nick C Fox, et al.
Annals of Neurology|November 22, 2023
Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital TestingKathryn V Papp, Roos J Jutten, Daniel Soberanes, et al.
Nature Reviews. Neurology|September 22, 2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseEric McDade, Iryna Voytyuk, Paul Aisen, et al.
Alzheimer'S Research & Therapy|May 2, 2023
Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitmentDylan R Kirn, Joshua D Grill, Paul Aisen, et al.
The Lancet. Neurology|October 19, 2016
Research priorities to reduce the global burden of dementia by 2025Hiral Shah, Emiliano Albanese, Cynthia Duggan, et al.
The Journal of Prevention of Alzheimer'S Disease|April 8, 2026
Late-life body mass index and amyloid interaction on cognitive decline in unimpaired older adultsWai-Ying Wendy Yau, Rema Raman, Jasmeer Chhatwal, et al.
Pageof 10